Olink Holding Ab Publ Revenue per Employee (OLK), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Olink Holding Ab publ   (NASDAQ: OLK)
 

Olink Holding Ab Publ 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


With a revenue increase of 21.18% in the fourth quarter 2023, year on year to cumulative value of $169 million, Olink Holding Ab Publ 's revenue per employee grew on a trailing twelve months basis to $ 423,653, this is below the company average.
Within the Healthcare sector Employees of 82 other companies have achieved higher revenue per employee. While Olink Holding Ab Publ 's total ranking has deteriorated compared to the previous quarter from 0 to 880. Olink Holding Ab Publ has 400 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

OLK Revenue per Employee (Dec 31 2023)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Dec 31 2022)
IV. Quarter
Y / Y Revenue Change 21.18 % - - - 47.25 %
Sales per Employee (TTM) $ 423,653 349,620 349,620 349,620 349,620
OLK's Total Ranking # 880 # 0 # 0 # 0 # 1295
Seq. Revenue Change - - - - -

OLK Company Profile >> Back to OLK Efficiency Comparisons >> Compare OLK Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Laboratory Analytical Instruments Industry # 3
Healthcare Sector # 83
Overall Market # 880

Revenue per Employee Statistics
High Average Low
$ 634,685 $ 504,722 $ 355,704
(Dec 31 2023)   (Dec 31 2021)



Financial Statements
Olink Holding Ab Publ 's Revenue MRQ $ 169 Millions Visit OLK's Income Statement
Olink Holding Ab Publ 's Revenues TTM $ 169 Millions Visit OLK's aggregate revenue growth
What are OLK's Sales? Visit OLK's Sales by Segment




Other Ratios
Olink Holding Ab Publ 's Income per Employee
Employees in Laboratory Analytical Instruments
Laboratory Analytical Instruments Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
OLK's Revenue per Employee versus Laboratory Analytical Instruments Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for OLK's Competitors
Revenue per Employee for OLK's Suppliers
Revenue per Employee for OLK's Customers

You may also want to know
OLK's Sales Growth Rates OLK's Pe Price to earnings ratio OLK's Receivables Turnover Ratio OLK's Stock Quote
OLK's Net Income Growth Rates OLK's Ps Price to Sales ratio OLK's Sales per Employee OLK's Asset Turnover Ratio
OLK's Net Margin OLK's Pb Price to Book ratio OLK's Financial Strength Ratios OLK's Dividend Payout Ratio
Date modified: 2026-09-08T15:11:13+00:00




Companies with similar Revenue per Employee for 12 months ending Dec 31 2023, within Healthcare Sector Revenue per Employee Revenue 12 months ending Dec 31 2023Number of Employees Dec 31 2023
Beam Therapeutics Inc   739,156.56 $ 377.709  Million 511 
Kiniksa Pharmaceuticals International Plc  738,412.57 $ 270.259  Million 366 
Galapagos Nv  735,591.45 $ 268.491  Million 365 
Alnylam Pharmaceuticals Inc   731,316.80 $ 1,828.292  Million 2,500 
Hookipa Pharma inc   718,892.86 $ 20.129  Million 28 
Precision Biosciences Inc  716,573.53 $ 48.727  Million 68 
Cidara Therapeutics Inc   714,579.71 $ 49.306  Million 69 
Eton Pharmaceuticals Inc   705,931.82 $ 31.061  Million 44 
Elite Pharmaceuticals Inc   705,850.31 $ 45.880  Million 65 
Ati Physical Therapy Inc   699,016.00 $ 699.016  Million 1,000 
Endo International Plc  686,290.69 $ 2,011.518  Million 2,931 
Eli Lilly And Company  682,482.00 $ 34,124.100  Million 50,000 
Opus Genetics Inc   680,321.43 $ 19.049  Million 28 
Rigel Pharmaceuticals Inc  671,735.63 $ 116.882  Million 174 
Xencor Inc  671,596.15 $ 174.615  Million 260 
Maravai Lifesciences Holdings Inc   664,241.38 $ 288.945  Million 435 
Corcept Therapeutics Inc  660,787.67 $ 482.375  Million 730 
Johnson and Johnson  660,667.61 $ 93,022.000  Million 140,800 
Cardiff Lexington Corporation  658,514.78 $ 11.853  Million 18 
Milestone Scientific Inc   652,840.80 $ 9.793  Million 15 
Quantum Biopharma Ltd   650,829.29 $ 4.556  Million 7 
Skinhealth Systems Inc   647,818.92 $ 397.113  Million 613 
Evoke Pharma Inc   647,578.75 $ 5.181  Million 8 
Palatin Technologies Inc   645,245.27 $ 7.098  Million 11 
Karyopharm Therapeutics Inc   640,495.61 $ 146.033  Million 228 
Theravance Biopharma inc   638,044.44 $ 57.424  Million 90 
Evofem Biosciences Inc   628,206.90 $ 18.218  Million 29 
Organon and Co   626,300.00 $ 6,263.000  Million 10,000 
Novartis Ag  619,926.40 $ 46,660.000  Million 75,267 
Enanta Pharmaceuticals Inc  613,516.67 $ 73.622  Million 120 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.